IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,856 | +160.2% | 495 | +209.4% | 0.00% | – |
Q2 2023 | $3,019 | +1190.2% | 160 | +162.3% | 0.00% | – |
Q1 2023 | $234 | -1.7% | 61 | +27.1% | 0.00% | – |
Q4 2022 | $238 | – | 48 | 0.0% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 48 | -81.0% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 253 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | +100.0% | 253 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | -50.0% | 253 | -6.6% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 271 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 271 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 271 | -52.6% | 0.00% | – |
Q3 2020 | $2,000 | -33.3% | 572 | 0.0% | 0.00% | – |
Q2 2020 | $3,000 | +50.0% | 572 | -5.8% | 0.00% | – |
Q1 2020 | $2,000 | -33.3% | 607 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | +50.0% | 607 | -13.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 698 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | +100.0% | 698 | +156.6% | 0.00% | – |
Q1 2019 | $1,000 | -50.0% | 272 | -28.0% | 0.00% | – |
Q4 2018 | $2,000 | 0.0% | 378 | +97.9% | 0.00% | – |
Q3 2018 | $2,000 | 0.0% | 191 | +15.8% | 0.00% | – |
Q2 2018 | $2,000 | -60.0% | 165 | -66.9% | 0.00% | -100.0% |
Q1 2018 | $5,000 | +150.0% | 499 | -16.7% | 0.00% | – |
Q3 2016 | $2,000 | – | 599 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |